Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Фибрилляция предсердий: эпидемиология, особенности течения разных форм и выживаемость больных на северо-западе России
Фибрилляция предсердий: эпидемиология, особенности течения разных форм и выживаемость больных на северо-западе России
Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Аннотация
(Ретроспективный 25-летний анализ)
В представленной статье проведен анализ частоты новых случаев (инцидентности), распространенности (превалентности), особенностей клинического течения и выживаемости больных при разных формах фибрилляции предсердий (ФП) за 25-летний период с 1980 по 2004 г. За анализируемый период показатель инцидентности увеличился в 5 раз, распространенности – в 6 раз. Более существенное увеличение распространенности произошло у мужчин (в 10 раз), менее значимое – у женщин (в 4 раза). Впервые выявлены разнонаправленные различия в показателях инцидентности у мужчин и женщин. При рецидивирующей бессимптомной форме ФП существенно снижается выживаемость больных.
Ключевые слова: фибрилляция предсердий, распространенность, инцидентность, бессимптомная форма, выживаемость, смертность.
In the present article is to analyze the frequency of new cases (incidence), prevalence (prevalence), clinical course and survival of patients with different forms of atrial fibrillation (AF) for a 25-year period from 1980 to 2004. During the analyzed period, the incidence has increased 5 times, the prevalence of 6 times. A more significant increase in prevalence has occurred among men (10 times), less significant – in women (4 times). For the first time revealed multidirectional differences in incidence among men and women. If recurrent, asymptomatic form of AF is significantly reduced survival.
Key words: atrial fibrillation, the prevalence, incidence, asymptomatic form, survival, mortality.
В представленной статье проведен анализ частоты новых случаев (инцидентности), распространенности (превалентности), особенностей клинического течения и выживаемости больных при разных формах фибрилляции предсердий (ФП) за 25-летний период с 1980 по 2004 г. За анализируемый период показатель инцидентности увеличился в 5 раз, распространенности – в 6 раз. Более существенное увеличение распространенности произошло у мужчин (в 10 раз), менее значимое – у женщин (в 4 раза). Впервые выявлены разнонаправленные различия в показателях инцидентности у мужчин и женщин. При рецидивирующей бессимптомной форме ФП существенно снижается выживаемость больных.
Ключевые слова: фибрилляция предсердий, распространенность, инцидентность, бессимптомная форма, выживаемость, смертность.
________________________________________________
In the present article is to analyze the frequency of new cases (incidence), prevalence (prevalence), clinical course and survival of patients with different forms of atrial fibrillation (AF) for a 25-year period from 1980 to 2004. During the analyzed period, the incidence has increased 5 times, the prevalence of 6 times. A more significant increase in prevalence has occurred among men (10 times), less significant – in women (4 times). For the first time revealed multidirectional differences in incidence among men and women. If recurrent, asymptomatic form of AF is significantly reduced survival.
Key words: atrial fibrillation, the prevalence, incidence, asymptomatic form, survival, mortality.
Полный текст
Список литературы
1. Кушаковский М.С. Фибрилляция предсердий. СПб.: Фолиант, 1999; с. 176.
2. Cердечная Е.В. Фибрилляция предсердий: особенности течения и выбора стратегии лечения. Под ред. Е.В.Сердечной, Б.А.Татарского. Монография. Архангельск. 2008; с. 78–79.
3. Татарский Б.А. Бессимптомная форма фибрилляции предсердий. Сердечная недостаточность. 2001; 5: 217–20.
4. Alpert JS. Atrial fibrillation: a growth industry in the 21st century. Eur Heart J 2000; 21: 1207–8.
5. Benjamin EJ, Wolf PA, Agostino RB et al. Impact of atrial fibrillation on the risk of death: the Framingha Heart Study. Circulation 1998; 98: 946–52.
6. Bialy D, Lehmann MN, Schumacher DN et al. Hospitalization for arrhithmias in the United States: importance of atrial fibrillation. J Am Coll Cardiol 1992: 19–41.
7. Cairns JA, Connolly SJ. Nonrheumatic atrial fibrillation: risk of stroke and role of antithrombotic therapy. Circulation 1991; 96: 711–6.
8. Elesber AA, Rosales AG, Herges RM et al. Relapse and mortality following cardioversion of new-onset vs. recurrent atrial fibrillation and atrial flutter in the elderly. Eur Heart J 2006; 7: 854–60.
9. Feinberg WM, Blackshear JL, Laupacis A et al. Prevalence, age distribution, and gender of patient with atrial fibrillation. Analysis and implication. Arh Intern Med 1995; 155: 469–73.
10. Friberg J, Scharling H, Gadsball N et al. Sex -specific increase in the prevalence of atrial fibrillation (The Copenhagen City Heart Study) Am J Cardiol 2003; 92.
11. Go A, Hylek EM, Phillips KA et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulations and Risk factors in Atrial Fibrillation (ATRIA) Study. JAMA 2001; 285: 2370–5.
12. Greg C, Belew K, Beckman K et al. Asymptomatic Atrial Fibrillation: Demographic Features and Prognostic Information From the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Study. Am Heart J 2005; 149 (4): 657–63.
13. Heeringa J, van der Kuip Deirdre, Hofman A et al. Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study. Eur Heart J 2006; 27: 949–53.
14. Jouven X, Desnos M, Guerot C et al. Idiopathic atrial fibrillation as a risk factor for mortality. The Paris Prospective Study I. Eur Heart J 1999; 20: 896–900.
15. Kannel WB, Abbott RD, Savage DD et al. Epidemiology features of chronic atrial fibrillation: the Framingem Study. N Eng J Med 1982; 306: 1018–22.
16. Kannel W, Abbott RD, Savage DD. Coronary heart disease and atrial fibrillation: The Framingham Study. Am Heart J 1983; 106: 389–96.
17. Majeed A, Moser K, Carroll K. Trends in Prevalence and managment of atrial fibrillation in England and Wales, 1994–1998: analysis of data from the general practice research database. Heart 2001; 86: 284–8.
18. Miyasaka Y, Barnes E, Bailey R et al. Mortality Trends in Patients Diagnosed With First Atrial Fibrillation. A 21-Year Community-Based Study. J Am Coll Cardiol 2007; 49: 986–92.
19. Miyasaka Y, Marion E, Barnes et al. Secular Trends in Incidence of Atrial Fibrillation in Olmsted Country, Minnecota, 1980 to 2000, and Implications on the Projections for Future Prevalence. Circulation 2006; 114: 119–25.
20. Psaty BM, Manolio TA, Kuller LH. Incidence of and risk factors for atrial fibrillation in older adults. Circulation 1997; 96: 2455–61.
21. Ruigomez A, Johansson S, Wallander MA. Risk of mortality in a cohort of patients newly diagnosed with chronic atrial fibrillation. BMC Cardiovasc Disord 2002; 2: 2–5.
22. Scardi S, Mazzone C, Pandullo C et al. Mortality and cause of death in patients with chronic non-rheumatic atrial fibrillation after two years follow-up. G Ital Cardiol 1999; 29: 637–46.
23. Stewart S, Hart CL, Hole DJ et al. A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley study. Am J Med 2002; 113: 359–64.
24. The Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Investigators. A comparison of rate control and rhythm control in patient with atrial fibrillation. N Eng J Med 2002; 347: 1852–33.
25. Tsang TS, Petty GW, Barnes ME et al. The prevalence ofatrial fibrillation in incident stroke cases and matched population controls in Rochester Minnesota. J Am Coll Cardiol 2003; 42: 93–100.
26. Update of the guidelines on sudden cardiac death of the European Society of Cardiology. Eur Heart J 2003; 24 (1): 13–5.
27. Wang Т, Larson M, Levy D. Temporal relaions of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingem Heart Study. Circulation 2003; 107: 2920–5.
2. Cердечная Е.В. Фибрилляция предсердий: особенности течения и выбора стратегии лечения. Под ред. Е.В.Сердечной, Б.А.Татарского. Монография. Архангельск. 2008; с. 78–79.
3. Татарский Б.А. Бессимптомная форма фибрилляции предсердий. Сердечная недостаточность. 2001; 5: 217–20.
4. Alpert JS. Atrial fibrillation: a growth industry in the 21st century. Eur Heart J 2000; 21: 1207–8.
5. Benjamin EJ, Wolf PA, Agostino RB et al. Impact of atrial fibrillation on the risk of death: the Framingha Heart Study. Circulation 1998; 98: 946–52.
6. Bialy D, Lehmann MN, Schumacher DN et al. Hospitalization for arrhithmias in the United States: importance of atrial fibrillation. J Am Coll Cardiol 1992: 19–41.
7. Cairns JA, Connolly SJ. Nonrheumatic atrial fibrillation: risk of stroke and role of antithrombotic therapy. Circulation 1991; 96: 711–6.
8. Elesber AA, Rosales AG, Herges RM et al. Relapse and mortality following cardioversion of new-onset vs. recurrent atrial fibrillation and atrial flutter in the elderly. Eur Heart J 2006; 7: 854–60.
9. Feinberg WM, Blackshear JL, Laupacis A et al. Prevalence, age distribution, and gender of patient with atrial fibrillation. Analysis and implication. Arh Intern Med 1995; 155: 469–73.
10. Friberg J, Scharling H, Gadsball N et al. Sex -specific increase in the prevalence of atrial fibrillation (The Copenhagen City Heart Study) Am J Cardiol 2003; 92.
11. Go A, Hylek EM, Phillips KA et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulations and Risk factors in Atrial Fibrillation (ATRIA) Study. JAMA 2001; 285: 2370–5.
12. Greg C, Belew K, Beckman K et al. Asymptomatic Atrial Fibrillation: Demographic Features and Prognostic Information From the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Study. Am Heart J 2005; 149 (4): 657–63.
13. Heeringa J, van der Kuip Deirdre, Hofman A et al. Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study. Eur Heart J 2006; 27: 949–53.
14. Jouven X, Desnos M, Guerot C et al. Idiopathic atrial fibrillation as a risk factor for mortality. The Paris Prospective Study I. Eur Heart J 1999; 20: 896–900.
15. Kannel WB, Abbott RD, Savage DD et al. Epidemiology features of chronic atrial fibrillation: the Framingem Study. N Eng J Med 1982; 306: 1018–22.
16. Kannel W, Abbott RD, Savage DD. Coronary heart disease and atrial fibrillation: The Framingham Study. Am Heart J 1983; 106: 389–96.
17. Majeed A, Moser K, Carroll K. Trends in Prevalence and managment of atrial fibrillation in England and Wales, 1994–1998: analysis of data from the general practice research database. Heart 2001; 86: 284–8.
18. Miyasaka Y, Barnes E, Bailey R et al. Mortality Trends in Patients Diagnosed With First Atrial Fibrillation. A 21-Year Community-Based Study. J Am Coll Cardiol 2007; 49: 986–92.
19. Miyasaka Y, Marion E, Barnes et al. Secular Trends in Incidence of Atrial Fibrillation in Olmsted Country, Minnecota, 1980 to 2000, and Implications on the Projections for Future Prevalence. Circulation 2006; 114: 119–25.
20. Psaty BM, Manolio TA, Kuller LH. Incidence of and risk factors for atrial fibrillation in older adults. Circulation 1997; 96: 2455–61.
21. Ruigomez A, Johansson S, Wallander MA. Risk of mortality in a cohort of patients newly diagnosed with chronic atrial fibrillation. BMC Cardiovasc Disord 2002; 2: 2–5.
22. Scardi S, Mazzone C, Pandullo C et al. Mortality and cause of death in patients with chronic non-rheumatic atrial fibrillation after two years follow-up. G Ital Cardiol 1999; 29: 637–46.
23. Stewart S, Hart CL, Hole DJ et al. A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley study. Am J Med 2002; 113: 359–64.
24. The Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Investigators. A comparison of rate control and rhythm control in patient with atrial fibrillation. N Eng J Med 2002; 347: 1852–33.
25. Tsang TS, Petty GW, Barnes ME et al. The prevalence ofatrial fibrillation in incident stroke cases and matched population controls in Rochester Minnesota. J Am Coll Cardiol 2003; 42: 93–100.
26. Update of the guidelines on sudden cardiac death of the European Society of Cardiology. Eur Heart J 2003; 24 (1): 13–5.
27. Wang Т, Larson M, Levy D. Temporal relaions of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingem Heart Study. Circulation 2003; 107: 2920–5.
Авторы
Е.В.Сердечная*1, С.В.Юрьева1, Б.А.Татарский2
1 ГБОУ ВПО Северный государственный медицинский университет
2 ФГБУ Федеральный центр сердца, крови и эндокринологии им. В.А.Алмазова Минздрава РФ
*Serdechny@yandex.ru
1 Northern State Medical University
2 V.A.Almazov Federal Heart, Blood, and Endocrinology Center, Ministry of Health of the Russian Federation, Saint Petersburg
*Serdechny@yandex.ru
1 ГБОУ ВПО Северный государственный медицинский университет
2 ФГБУ Федеральный центр сердца, крови и эндокринологии им. В.А.Алмазова Минздрава РФ
*Serdechny@yandex.ru
________________________________________________
1 Northern State Medical University
2 V.A.Almazov Federal Heart, Blood, and Endocrinology Center, Ministry of Health of the Russian Federation, Saint Petersburg
*Serdechny@yandex.ru
Цель портала OmniDoctor – предоставление профессиональной информации врачам, провизорам и фармацевтам.